[ad_1]
The Europeans had ordered 400 million cans of Astra, and the Austrians should have two millionis are delivered in March. Hope of being able to vaccinate everyone over 65 by the end of the first trimester is dwindling.
In fact, the EU had done everything right: negotiations with the main pharmaceutical companies had been going on since the summer of 2020t and venture capital provided. The Europeans’ calculation was logical: the greater the vaccine potential reserved by different drug companies, the greater the chance that one, two, maybe three companies could eventually produce an effective vaccine.
So it was, of all things, a German pharmaceutical dwarf like Biontech made the breakthrough before Christmas. Its vaccine, later marketed in cooperation with giant Pfizer, is the most effective to date at 95 percent. A little later, the Americans followed with Moderna, 140 million cans were ordered for the EU.
And now Astra Zeneca, with the vaccine there is of From the beginning Problems: Significantly less effective, although still much, much better than not having one; Problems with efficacy in the elderly are unclear at this time. And now also a fire in one of the most important supplier plants.
Criticisms that Israel, the US, the UK or Bahrain have negotiated better conditions are legitimate, but not necessarily fair: it is true that these states apparently have treaties according to which they are ahead of the Europeans. But we also have to realize that all the other 190 countries in the world will come after us. Or as a friend from Paraguay tells us: Everyone will be vaccinated there, but not before 2022.
So we have to stay quiet for the moment locked in and wait for other solutions to be found.
